PACS Links
What is PACS?
What is a Field Reimbursement Specialist?
PACS reviews
Why certify?
PACS price
PACS recertification
PACS extension
PACS FAQs
Quick contact
info@acmainfo.org
Buy and bill is central to how many specialty injectables reach patients, and the decision to adopt it sits with the provider. In this workshop, attendees will learn how the model works, how it gets reimbursed, and what a practice weighs before bringing on a new buy and bill product.
Ned Woody MBA PACS
Former Executive Associate Director, Quality and Value-Based Care at Daiichi Sankyo, Inc
This webinar has already taken place
Your providers don’t need you to explain what Buy and Bill is.
They need you to understand what happens when reimbursement doesn’t cover acquisition cost. When a claim is at risk of denial after the drug has already been administered. When payer requirements change. When inventory, coding, prior authorization, and reimbursement collide.
And they need FRMs who know what to do next.
Join Ned Woody, Daiichi Sankyo, former Executive Associate Director, Quality and Value-Based Care Initiatives, Daiichi Sankyo US, Field Reimbursement thought leader with over 30 years recognized for not only successful strategies, but the “hands on, day to day HCP in trenches experiences”, for an intensive 90 minute live virtual ACMA workshop built specifically around the real world challenges facing Field Reimbursement teams.
Ned will go beyond the mechanics of Buy and Bill to give FRMs and their managers actionable tools, ideas and strategies they can immediately apply in the field.
In 90 minutes, you’ll learn how to:
Buy and bill is central to how many specialty injectables reach patients, and the decision to adopt it sits with the provider. In this workshop, attendees will learn how the model works, how it gets reimbursed, and what a practice weighs before bringing on a new buy and bill product.
Ned Woody MBA PACS
Former Executive Associate Director, Quality and Value-Based Care at Daiichi Sankyo, Inc
This webinar has already taken place
Your providers don’t need you to explain what Buy and Bill is.
They need you to understand what happens when reimbursement doesn’t cover acquisition cost. When a claim is at risk of denial after the drug has already been administered. When payer requirements change. When inventory, coding, prior authorization, and reimbursement collide.
And they need FRMs who know what to do next.
Join Ned Woody, Daiichi Sankyo, former Executive Associate Director, Quality and Value-Based Care Initiatives, Daiichi Sankyo US, Field Reimbursement thought leader with over 30 years recognized for not only successful strategies, but the “hands on, day to day HCP in trenches experiences”, for an intensive 90 minute live virtual ACMA workshop built specifically around the real world challenges facing Field Reimbursement teams.
Ned will go beyond the mechanics of Buy and Bill to give FRMs and their managers actionable tools, ideas and strategies they can immediately apply in the field.
In 90 minutes, you’ll learn how to: